Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
Source abstract
Abstract
Bone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of a triphasic BVF loaded with common antibiotics. BVF was mixed with vancomycin and/or tobramycin to form pellets, and the set time was recorded. A partial refreshment elution study was conducted with time points at 4, 8, and 24 h, as well as 2, 7, 14, 28, and 42 days. Effects on dissolution were evaluated in a 14-day dissolution study. Set time increased to over 1 h for groups containing tobramycin, although vancomycin had a minimal effect. Pellets continued to elute antibiotics throughout the 42-day elution study, suggesting efficacy for the treatment or prevention of orthopedic infections. BVF containing vancomycin or tobramycin showed similar dissolution at 14 days compared to BVF without antibiotics; however, BVF containing both antibiotics showed significantly more dissolution.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, University of Memphis, Memphis, TN 38152, USA
Northside Hospital System, Atlanta, GA 30342, USA
Division of Orthopaedics, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
References (45)
Show source-provided references
1. Plaster: A bone substitute10.1016/0030-4220(66)90045-4 ↗
2. Bone grafts and bone substitutes in hip and knee surgery
3. Introduction to bone grafting10.1016/S1067-2516(96)80067-6 ↗
4. Use of bone-graft substitutes in distal radius fractures10.5435/00124635-199909000-00001 ↗
5. Calcium sulfate- and calcium phosphate–based bone substitutes: Mimicry of the mineral phase of bone
6. The use of calcium phosphate bone cement in fracture treatment: A meta-analysis of randomized trials10.2106/JBJS.G.00241 ↗
7. Bone substitutes in the netherlands—A systematic literature review10.1016/j.actbio.2010.07.035 ↗
8. Calcium sulfate bone void filler: A review and a look ahead10.1097/00001665-200011040-00009 ↗
9. Bone graft substitutes currently available in orthopaedic practice: The evidence for their use10.1302/0301-620X.95B5.30286 ↗
10. Bone substitutes in orthopaedic surgery: From basic science to clinical practice10.1007/s10856-014-5240-2 ↗
11. A level-1 pilot study to evaluate of ultraporous β-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis10.1007/s00586-008-0844-1 ↗
12. Calcium phosphate-based osteoinductive materials10.1021/cr800427g ↗
13. Calcium orthophosphate cements for biomedical application10.1007/s10853-008-2527-z ↗
14. Calcium phosphates: What is the evidence?10.1097/BOT.0b013e3181cec472 ↗
15. The composite of hydroxyapatite and calcium sulphate: A review of preclinical evaluation and clinical applications10.1586/17434440.2013.827529 ↗
16. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement10.2106/JBJS.E.01126 ↗
17. Local antibiotic therapy strategies in orthopaedic trauma: Practical tips and tricks and review of the literature10.1016/j.injury.2015.05.008 ↗
18. Calcium phosphate cements as drug delivery materials10.1016/j.addr.2012.01.008 ↗
19. Calcium phosphate cements as bone drug delivery systems: A review10.1016/j.jconrel.2006.04.007 ↗
20. Calcium sulfate: Properties and clinical applications10.1002/jbm.b.31269 ↗
21. Comparative performance of three ceramic bone graft substitutes10.1016/j.spinee.2006.07.017 ↗
22. The use of a surgical grade calcium sulfate as a bone graft substitute: Results of a multicenter trial10.1097/00003086-200101000-00008 ↗
23. Adverse reactions to osteoset bone graft substitute: The incidence in a consecutive series
24. No effect of osteoset®, a bone graft substitute, on bone healing in humans: A prospective randomized double-blind study10.1080/000164702321022875 ↗
25. Inflammatory reactions associated with a calcium sulfate bone substitute
26. Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors10.1002/jbm.b.30136 ↗
27. Β-tcp bone graft substitutes in a bilateral rabbit tibial defect model10.1016/j.biomaterials.2007.09.035 ↗
28. Histologic evaluation of a hydroxyapatite onlay bone graft retrieved after 9 years: A clinical report10.1067/mpr.2002.122961 ↗
29. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant staphylococcus aureus strains10.1128/AAC.22.5.903 ↗
30. Elution characteristics of vancomycin and tobramycin combined in acrylic bone—Cement10.1016/S0883-5403(96)80135-5 ↗
31. Osteomyelitis: Clinical update for practical guidelines10.1097/00006231-200608000-00007 ↗
32. Solid-state properties of tobramycin10.1023/A:1015858503031 ↗
33. Generic tobramycin elutes from bone cement faster than proprietary tobramycin10.1007/s11999-008-0199-2 ↗
34. The effect of sampling method on the elution of tobramycin from calcium sulfate10.1097/00003086-200210000-00010 ↗
35. Reconstruction of bone defects after osteomyelitis with nonvascularized fibular graft: A retrospective study in twenty-six children10.2106/JBJS.K.01338 ↗
36. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion10.1097/BOT.0b013e3181df91d9 ↗
37. Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: An in vitro elution study10.1089/sur.2013.162 ↗
38. Comparing PMMA and calcium sulfate as carriers for the local delivery of antibiotics to infected surgical sites10.1002/jbm.b.33247 ↗
39. The in vitro elution characteristics of vancomycin and tobramycin from calcium sulfate beads10.1053/j.jfas.2005.01.006 ↗
40. Transforming growth factor-beta1 incorporation in a calcium phosphate bone cement: Material properties and release characteristics10.1002/jbm.1241 ↗
41. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system?10.1016/j.biomaterials.2005.11.023 ↗
42. Elution profiles of tobramycin and vancomycin from high-purity calcium sulphate beads incubated in a range of simulated body fluids10.1177/0885328216663392 ↗
43. In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: Fine structural microscopy10.1002/jbm.a.10091 ↗
44. Osteogenic biphasic calcium sulphate dihydrate/iron-modified α-tricalcium phosphate bone cement for spinal applications: In vivo study10.1016/j.actbio.2009.07.010 ↗
45. High-performance liquid chromatography method for the determination of aminoglycosides based on automated pre-column derivatization with o-phthalaldehyde10.1016/0021-9673(92)80268-Y ↗